Ashton Thomas Securities’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$326K Buy
3,777
+108
+3% +$8.99K 0.03% 307
2026
Q2
$247K Buy
+3,669
New +$244K 0.04% 276
2024
Q4
– Sell
-1,260
Closed -$84.5K – 491
2024
Q3
$84.5K Sell
1,260
-6,537
-84% -$537K 0.02% 347
2024
Q2
$864K Buy
+7,797
New +$986K 0.21% 115

Other funds holding DXCM

Ashton Thomas Securities's DXCM Position: Q3 2026 in Review

Ashton Thomas Securities increased its DexCom (DXCM) stake by 2.9% in Q3 2026, buying an estimated $8.99K and bringing the position to 3,777 shares worth $326K. The position accounts for 0.03% of the portfolio, ranked #307.

Ashton Thomas Securities first reported a position in DXCM in Q2 2024 and has held it in 4 quarters since. The position peaked at $864K in Q2 2024. 562 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Ashton Thomas Securities held 3,777 shares of DexCom worth $326K as of Q3 2026.
  • Ashton Thomas Securities bought 108 DexCom shares in Q3 2026, an estimated $8.99K.
  • DexCom made up 0.03% of Ashton Thomas Securities's portfolio in Q3 2026, its #307 holding.
  • Ashton Thomas Securities first reported a position in DexCom in Q2 2024 and has held it in 4 quarters since.
  • Ashton Thomas Securities's DexCom position peaked at $864K in Q2 2024.
  • 562 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Ashton Thomas Securities's 13F filing for Q3 2026, filed 26 Oct 2026.